X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with JUBILANT LIFE SCIENCES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs JUBILANT LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE JUBILANT LIFE SCIENCES TTK HEALTHCARE/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 50.7 29.3 173.1% View Chart
P/BV x 9.3 6.0 155.3% View Chart
Dividend Yield % 0.3 0.3 102.9%  

Financials

 TTK HEALTHCARE   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
JUBILANT LIFE SCIENCES
Mar-14
TTK HEALTHCARE/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs663187 355.1%   
Low Rs39965 612.9%   
Sales per share (Unadj.) Rs535.6364.3 147.0%  
Earnings per share (Unadj.) Rs15.96.8 232.9%  
Cash flow per share (Unadj.) Rs20.024.5 81.7%  
Dividends per share (Unadj.) Rs4.003.00 133.3%  
Dividend yield (eoy) %0.82.4 31.6%  
Book value per share (Unadj.) Rs137.6164.9 83.5%  
Shares outstanding (eoy) m7.77159.28 4.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.00.3 286.9%   
Avg P/E ratio x33.318.4 181.1%  
P/CF ratio (eoy) x26.55.1 516.0%  
Price / Book Value ratio x3.90.8 505.4%  
Dividend payout %25.143.8 57.2%   
Avg Mkt Cap Rs m4,12720,061 20.6%   
No. of employees `0001.76.2 27.6%   
Total wages/salary Rs m60711,052 5.5%   
Avg. sales/employee Rs Th2,436.79,383.0 26.0%   
Avg. wages/employee Rs Th355.21,786.9 19.9%   
Avg. net profit/employee Rs Th72.5176.3 41.1%   
INCOME DATA
Net Sales Rs m4,16258,034 7.2%  
Other income Rs m61191 32.1%   
Total revenues Rs m4,22358,224 7.3%   
Gross profit Rs m1975,786 3.4%  
Depreciation Rs m322,812 1.1%   
Interest Rs m303,237 0.9%   
Profit before tax Rs m197-72 -272.8%   
Minority Interest Rs m0-286 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m02,145 0.0%   
Tax Rs m73696 10.5%   
Profit after tax Rs m1241,090 11.4%  
Gross profit margin %4.710.0 47.5%  
Effective tax rate %37.0-965.9 -3.8%   
Net profit margin %3.01.9 158.4%  
BALANCE SHEET DATA
Current assets Rs m1,62929,280 5.6%   
Current liabilities Rs m1,05838,912 2.7%   
Net working cap to sales %13.7-16.6 -82.7%  
Current ratio x1.50.8 204.6%  
Inventory Days Days3084 35.3%  
Debtors Days Days3451 66.3%  
Net fixed assets Rs m55655,712 1.0%   
Share capital Rs m78155 50.3%   
"Free" reserves Rs m87820,968 4.2%   
Net worth Rs m1,06926,265 4.1%   
Long term debt Rs m15917,169 0.9%   
Total assets Rs m2,39988,606 2.7%  
Interest coverage x7.61.0 775.1%   
Debt to equity ratio x0.10.7 22.7%  
Sales to assets ratio x1.70.7 264.8%   
Return on assets %6.44.9 131.2%  
Return on equity %11.64.2 279.1%  
Return on capital %18.511.6 159.5%  
Exports to sales %0.837.8 2.1%   
Imports to sales %1.416.5 8.5%   
Exports (fob) Rs m3321,933 0.2%   
Imports (cif) Rs m589,567 0.6%   
Fx inflow Rs m3322,004 0.1%   
Fx outflow Rs m6311,749 0.5%   
Net fx Rs m-3010,255 -0.3%   
CASH FLOW
From Operations Rs m1278,026 1.6%  
From Investments Rs m-146-1,744 8.4%  
From Financial Activity Rs m22-4,447 -0.5%  
Net Cashflow Rs m31,834 0.1%  

Share Holding

Indian Promoters % 65.4 45.6 143.4%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 3.7 8.7 42.5%  
FIIs % 5.2 21.2 24.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 21.1 122.3%  
Shareholders   12,723 23,815 53.4%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   GLENMARK PHARMA  UNICHEM LAB  DR. REDDYS LAB  DIVIS LABORATORIES  ALEMBIC LTD  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Day Flat; Oil and Gas Stocks Lead Losses(Closing)

After opening the day in red, share markets in India witnessed negative trading activity throughout the day and ended the day on a weak note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 22, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - NATCO PHARMA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS